home All News open_in_new Full Article

New personalized skin cancer treatment shows success in preventing return of high

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, pharmaceutical companies Moderna and Merck announced in five-year findings.


today 9 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Science
attach_file Politics
attach_file Economics
attach_file Science
attach_file Science
attach_file Events
attach_file Events
attach_file Science
attach_file Politics
attach_file Science
attach_file Science
attach_file Science
attach_file Economics
attach_file Science
attach_file Science
attach_file Science


ID: 10247830
Add Watch Country

arrow_drop_down